Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00730886 · ClinicalTrials.gov registry record · NA
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
A NA study, sponsored by InSightec.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT00730886: Clinical Trial NA study, sponsored by InSightec.
NCT00730886 is a NA study that was terminated before completion, run by InSightec. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00730886, a NA study, was terminated before completion, sponsored by InSightec.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The objective of this trial is to evaluate the efficacy and safety of the ExAblate 2000 system for enhancement of fertility in women with non-hysteroscopically resectable uterine fibroids, who are diagnosed with unexplained infertility. Uterine fibroids are fairly common in women of child-bearing age. An evidence based review supported removing fibroids that distort the uterine cavity to increase pregnancy rates and decrease the rates of miscarriage. Some fibroids can be removed hysteroscopically which is minimally invasive, with low morbidity. However, removal of fibroids within the uterine wall require more invasive surgical procedures (e.g., myomectomy), with increasing morbidity risks including, but not limited to, infection, blood loss and postoperative uterine adhesions. ExAblate is approved by FDA for the treatment of uterine fibroids; however, its use in patients seeking pregnancy is considered experimental. Accumulated evidence suggests there are no significant complications from the procedure in women seeking pregnancy as with existing fibroid therapies; however, these data are based on a small number of patients. This study will evaluate fertility enhancement following ExAblate treatment or myomectomy, in women with unexplained infertility and who have non-hysteroscopically resectable uterine fibroids.
Interventions
- DEVICE ExAblate 2000
- PROCEDURE Myomectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2008-07 |
| Est. Completion | 2011-10-06 |
| Phase | NA |
Why NCT00730886 stopped before completion
NCT00730886 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which ExAblate 2000 is the first listed.
NCT00730886 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00730886 about?
NCT00730886 is a clinical study titled "ExAblate Treatment of Uterine Fibroids for Fertility Enhancement". The objective of this trial is to evaluate the efficacy and safety of the ExAblate 2000 system for enhancement of fertility in women with non-hysteroscopically resectable uterine fibroids, who are diagnosed with unexplained infertility. Uterine fibroids are fairly common in women of child-bearing a...
What is the current status of trial NCT00730886?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2008-07. Estimated completion is 2011-10-06.
What interventions are being tested in trial NCT00730886?
The interventions under investigation include: ExAblate 2000 (DEVICE), Myomectomy (PROCEDURE).
Who is sponsoring clinical trial NCT00730886?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00730886's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia